| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL | 55 |
| 1 | RIVAROXABAN | 32 |
| 2 | ASPIRIN | 24 |
| 3 | ASPIRIN 325 MG | 22 |
| 4 | ASPIRIN 81 MG | 22 |
| 5 | BACLOFEN | 22 |
| 6 | CLOPIDOGREL | 22 |
| 7 | CLOPIDOGREL BISULFATE | 22 |
| 8 | WARFARIN | 15 |
| 9 | FUROSEMIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BACLOFEN INJECTION | 9 | 0.0029 |
| 1 | DANTROLENE SODIUM | 2 | 0.0017 |
| 2 | ETONOGESTREL | 55 | 0.0010 |
| 3 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 7 | 0.0009 |
| 4 | ZICONOTIDE ACETATE | 2 | 0.0008 |
| 5 | BUPIVACAINE | 7 | 0.0007 |
| 6 | CEFAZOLIN SODIUM | 7 | 0.0006 |
| 7 | DOBUTAMINE | 2 | 0.0005 |
| 8 | DUTASTERIDE | 3 | 0.0004 |
| 9 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 57 |
| 1 | Factor Xa Inhibitor [EPC] | 43 |
| 2 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 31 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 20 |
| 6 | Loop Diuretic [EPC] | 14 |
| 7 | Osmotic Laxative [EPC] | 8 |
| 8 | beta-Adrenergic Blocker [EPC] | 8 |
| 9 | Amide Local Anesthetic [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 31 | 0.0003 |
| 1 | Progestin [EPC] | 57 | 0.0002 |
| 2 | P2Y12 Platelet Inhibitor [EPC] | 20 | 0.0002 |
| 3 | Factor Xa Inhibitor [EPC] | 43 | 0.0002 |
| 4 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 5 | Glinide [EPC] | 1 | 0.0001 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 6 | 0.0001 |
| 7 | Anti-anginal [EPC] | 1 | 0.0001 |
| 8 | Amide Local Anesthetic [EPC] | 7 | 0.0001 |
| 9 | Vitamin D Analog [EPC] | 1 | 0.0001 |